Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527

Condition:   Healthy Volunteer Study Interventions:   Drug: Period 1: AT-527 550 mg;   Drug: Period 2: carbamazepine;   Drug: Period 3: AT-527 550 mg + carbamazepine;   Drug: Period 3: AT-527 1100 mg + carbamazepine Sponsors:   Atea Pharmaceuticals, Inc.;   Hoffmann-La Roche Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials